Probiotic supplementation influences faecal short chain fatty acids in infants at high risk for eczema

H K Kim1,2, N B M M Rutten3, I Besseling-van der Vaart2

  • 11 Natural Product Laboratory, Institute of Biology, Leiden University, P.O. Box 9502, 2300 RA Leiden, the Netherlands.

Beneficial Microbes
|November 14, 2015
PubMed

Insights

Probiotic supplementation in infants may prevent eczema by altering gut bacteria metabolites. Early gut metabolic differences were observed in children who later developed eczema, suggesting a role in immune system development.

Area of Science:

  • Microbiology
  • Immunology
  • Metabolomics

Background:

  • Gut microbiota composition influences allergy development.
  • Probiotics are investigated for preventing childhood eczema due to their immunomodulating effects.
  • Previous research indicated reduced eczema incidence with specific probiotic strains at three months of age.

Purpose of the Study:

  • To investigate gut metabolic alterations in infants using (1)H-nuclear magnetic resonance (NMR) spectroscopy.
  • To identify specific fecal metabolites associated with eczema development in early childhood.
  • To explore the impact of probiotic supplementation on infant gut metabolomics.

Main Methods:

  • Analysis of fecal samples from 3-month-old infants using (1)H-NMR.
  • Comparison of metabolite profiles between infants who developed eczema and those who did not.
  • Assessment of metabolite changes in infants receiving probiotic supplementation versus placebo.

Main Results:

  • Infants later developing eczema showed lower levels of short-chain fatty acids (SCFAs), succinate, phenylalanine, and alanine, and higher levels of glucose, galactose, lactate, and lactose at 3 months.
  • Probiotic supplementation was associated with increased lactate and SCFAs, and decreased lactose and succinate compared to placebo.
  • Metabolic alterations were detectable at 3 months, preceding the clinical manifestation of eczema, which often appeared by 1 year of age.

Conclusions:

  • Gut bacterial metabolites play a role in immune system development and may influence the onset of allergic diseases like eczema.
  • Early-life metabolic profiles in the gut could serve as potential biomarkers for eczema risk.
  • Probiotics may exert a preventive effect on eczema development through modulation of gut metabolites, such as increasing SCFAs and lactate.

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
34
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
174
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
91.4K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
37
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
60